nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—PTGS2—skin cancer	0.193	1	CbGaD
Diclofenac—ABCC1—Vemurafenib—skin cancer	0.0616	0.116	CbGbCtD
Diclofenac—ABCC1—Dactinomycin—skin cancer	0.0409	0.0769	CbGbCtD
Diclofenac—ALB—Vismodegib—skin cancer	0.036	0.0675	CbGbCtD
Diclofenac—ABCC4—Fluorouracil—skin cancer	0.0345	0.0647	CbGbCtD
Diclofenac—CYP1A2—Imiquimod—skin cancer	0.031	0.0583	CbGbCtD
Diclofenac—CYP1A1—Dacarbazine—skin cancer	0.0292	0.0548	CbGbCtD
Diclofenac—ALB—Vemurafenib—skin cancer	0.0284	0.0534	CbGbCtD
Diclofenac—CYP2C8—Vismodegib—skin cancer	0.0278	0.0522	CbGbCtD
Diclofenac—CYP2C19—Vismodegib—skin cancer	0.0233	0.0438	CbGbCtD
Diclofenac—CYP2E1—Dacarbazine—skin cancer	0.0225	0.0423	CbGbCtD
Diclofenac—ABCC1—Docetaxel—skin cancer	0.0211	0.0397	CbGbCtD
Diclofenac—CYP2C9—Vismodegib—skin cancer	0.0194	0.0364	CbGbCtD
Diclofenac—ABCB1—Vismodegib—skin cancer	0.0188	0.0353	CbGbCtD
Diclofenac—CYP1A2—Vemurafenib—skin cancer	0.017	0.0319	CbGbCtD
Diclofenac—CYP3A4—Temozolomide—skin cancer	0.0163	0.0305	CbGbCtD
Diclofenac—CYP3A4—Imiquimod—skin cancer	0.0163	0.0305	CbGbCtD
Diclofenac—CYP1A2—Dacarbazine—skin cancer	0.013	0.0245	CbGbCtD
Diclofenac—ALB—Fluorouracil—skin cancer	0.0128	0.024	CbGbCtD
Diclofenac—CYP3A4—Vismodegib—skin cancer	0.0113	0.0212	CbGbCtD
Diclofenac—ABCB1—Dactinomycin—skin cancer	0.00988	0.0186	CbGbCtD
Diclofenac—CYP2C8—Fluorouracil—skin cancer	0.00987	0.0185	CbGbCtD
Diclofenac—CYP3A4—Vemurafenib—skin cancer	0.00891	0.0167	CbGbCtD
Diclofenac—CYP1A2—Fluorouracil—skin cancer	0.00764	0.0144	CbGbCtD
Diclofenac—CYP2C9—Fluorouracil—skin cancer	0.00688	0.0129	CbGbCtD
Diclofenac—ABCB1—Docetaxel—skin cancer	0.0051	0.00958	CbGbCtD
Diclofenac—CYP3A4—Docetaxel—skin cancer	0.00306	0.00574	CbGbCtD
Diclofenac—PLA2G2A—nipple—skin cancer	0.00138	0.0325	CbGeAlD
Diclofenac—CXCL8—nipple—skin cancer	0.00137	0.0322	CbGeAlD
Diclofenac—PTGS2—leg—skin cancer	0.00118	0.0277	CbGeAlD
Diclofenac—ASIC1—female reproductive system—skin cancer	0.00115	0.027	CbGeAlD
Diclofenac—CXCR1—lymph node—skin cancer	0.00113	0.0265	CbGeAlD
Diclofenac—PTGS2—hindlimb—skin cancer	0.00105	0.0247	CbGeAlD
Diclofenac—TTR—neck—skin cancer	0.00103	0.0243	CbGeAlD
Diclofenac—PLA2G2A—connective tissue—skin cancer	0.00098	0.023	CbGeAlD
Diclofenac—ASIC1—head—skin cancer	0.000958	0.0225	CbGeAlD
Diclofenac—PLA2G2A—epithelium—skin cancer	0.000931	0.0219	CbGeAlD
Diclofenac—KCNQ3—female reproductive system—skin cancer	0.000912	0.0214	CbGeAlD
Diclofenac—PTGS2—appendage—skin cancer	0.000902	0.0212	CbGeAlD
Diclofenac—CYP1A1—skin epidermis—skin cancer	0.000893	0.021	CbGeAlD
Diclofenac—KCNQ2—female reproductive system—skin cancer	0.00084	0.0197	CbGeAlD
Diclofenac—ABCC1—hair follicle—skin cancer	0.000811	0.0191	CbGeAlD
Diclofenac—PLA2G2A—mammalian vulva—skin cancer	0.000807	0.019	CbGeAlD
Diclofenac—KCNQ3—head—skin cancer	0.000762	0.0179	CbGeAlD
Diclofenac—PTGS2—skin epidermis—skin cancer	0.00075	0.0176	CbGeAlD
Diclofenac—TTR—connective tissue—skin cancer	0.00074	0.0174	CbGeAlD
Diclofenac—CYP2C18—mammalian vulva—skin cancer	0.000737	0.0173	CbGeAlD
Diclofenac—Bromfenac—PTGS2—skin cancer	0.000717	0.261	CrCbGaD
Diclofenac—PLA2G2A—lymphoid tissue—skin cancer	0.000717	0.0168	CbGeAlD
Diclofenac—KCNQ2—head—skin cancer	0.000702	0.0165	CbGeAlD
Diclofenac—PLA2G2A—female reproductive system—skin cancer	0.000691	0.0163	CbGeAlD
Diclofenac—ASIC1—lymph node—skin cancer	0.000671	0.0158	CbGeAlD
Diclofenac—ALOX5—connective tissue—skin cancer	0.000671	0.0158	CbGeAlD
Diclofenac—Lumiracoxib—PTGS2—skin cancer	0.00061	0.222	CrCbGaD
Diclofenac—UGT2B7—female reproductive system—skin cancer	0.000582	0.0137	CbGeAlD
Diclofenac—Nepafenac—PTGS2—skin cancer	0.00058	0.211	CrCbGaD
Diclofenac—PLA2G2A—head—skin cancer	0.000578	0.0136	CbGeAlD
Diclofenac—PTGS1—endothelium—skin cancer	0.000569	0.0134	CbGeAlD
Diclofenac—SLC22A11—female reproductive system—skin cancer	0.000567	0.0133	CbGeAlD
Diclofenac—ABCC1—nipple—skin cancer	0.00055	0.0129	CbGeAlD
Diclofenac—PTGS2—endothelium—skin cancer	0.000544	0.0128	CbGeAlD
Diclofenac—TTR—lymphoid tissue—skin cancer	0.000541	0.0127	CbGeAlD
Diclofenac—PTGS1—blood vessel—skin cancer	0.000525	0.0123	CbGeAlD
Diclofenac—TTR—female reproductive system—skin cancer	0.000522	0.0123	CbGeAlD
Diclofenac—PTGS2—blood vessel—skin cancer	0.000502	0.0118	CbGeAlD
Diclofenac—ALOX5—lymphoid tissue—skin cancer	0.00049	0.0115	CbGeAlD
Diclofenac—SLCO1C1—head—skin cancer	0.000488	0.0115	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—skin cancer	0.000475	0.173	CrCbGaD
Diclofenac—ALOX5—female reproductive system—skin cancer	0.000473	0.0111	CbGeAlD
Diclofenac—SCN4A—head—skin cancer	0.000448	0.0105	CbGeAlD
Diclofenac—CYP1A2—nipple—skin cancer	0.000438	0.0103	CbGeAlD
Diclofenac—TTR—head—skin cancer	0.000436	0.0102	CbGeAlD
Diclofenac—CYP1A1—nipple—skin cancer	0.000432	0.0102	CbGeAlD
Diclofenac—PLA2G2A—lymph node—skin cancer	0.000405	0.00951	CbGeAlD
Diclofenac—CXCL8—lymph node—skin cancer	0.0004	0.00941	CbGeAlD
Diclofenac—ALOX5—head—skin cancer	0.000395	0.00929	CbGeAlD
Diclofenac—PTGS1—nipple—skin cancer	0.00038	0.00892	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—skin cancer	0.000369	0.134	CrCbGaD
Diclofenac—SLCO1C1—lymph node—skin cancer	0.000342	0.00803	CbGeAlD
Diclofenac—ABCC4—female reproductive system—skin cancer	0.000323	0.00758	CbGeAlD
Diclofenac—ABCC1—mammalian vulva—skin cancer	0.000321	0.00755	CbGeAlD
Diclofenac—ABCB1—blood vessel—skin cancer	0.00031	0.0073	CbGeAlD
Diclofenac—CYP1A1—epithelium—skin cancer	0.000291	0.00684	CbGeAlD
Diclofenac—CYP1A1—skin of body—skin cancer	0.000277	0.0065	CbGeAlD
Diclofenac—ALOX5—lymph node—skin cancer	0.000277	0.0065	CbGeAlD
Diclofenac—ABCC4—head—skin cancer	0.000269	0.00633	CbGeAlD
Diclofenac—PTGS1—connective tissue—skin cancer	0.000269	0.00633	CbGeAlD
Diclofenac—CYP2B6—skin of body—skin cancer	0.000269	0.00632	CbGeAlD
Diclofenac—SLC22A8—head—skin cancer	0.000267	0.00628	CbGeAlD
Diclofenac—PTGS2—connective tissue—skin cancer	0.000257	0.00605	CbGeAlD
Diclofenac—PTGS1—epithelium—skin cancer	0.000256	0.00601	CbGeAlD
Diclofenac—CYP1A1—mammalian vulva—skin cancer	0.000252	0.00593	CbGeAlD
Diclofenac—PTGS2—epithelium—skin cancer	0.000244	0.00574	CbGeAlD
Diclofenac—PTGS1—skin of body—skin cancer	0.000243	0.00571	CbGeAlD
Diclofenac—CYP2C8—female reproductive system—skin cancer	0.000234	0.0055	CbGeAlD
Diclofenac—PTGS2—skin of body—skin cancer	0.000232	0.00546	CbGeAlD
Diclofenac—PTGS1—mammalian vulva—skin cancer	0.000222	0.00521	CbGeAlD
Diclofenac—CYP2B6—lymphoid tissue—skin cancer	0.000218	0.00512	CbGeAlD
Diclofenac—CYP1A1—female reproductive system—skin cancer	0.000216	0.00508	CbGeAlD
Diclofenac—CYP2B6—female reproductive system—skin cancer	0.00021	0.00494	CbGeAlD
Diclofenac—CYP2C9—female reproductive system—skin cancer	0.000208	0.00489	CbGeAlD
Diclofenac—CYP2E1—lymphoid tissue—skin cancer	0.000204	0.0048	CbGeAlD
Diclofenac—CYP2E1—female reproductive system—skin cancer	0.000197	0.00463	CbGeAlD
Diclofenac—ALB—lymph node—skin cancer	0.000195	0.00458	CbGeAlD
Diclofenac—PTGS1—female reproductive system—skin cancer	0.00019	0.00446	CbGeAlD
Diclofenac—ABCC4—lymph node—skin cancer	0.000189	0.00443	CbGeAlD
Diclofenac—PTGS2—lymphoid tissue—skin cancer	0.000188	0.00442	CbGeAlD
Diclofenac—PTGS2—female reproductive system—skin cancer	0.000181	0.00427	CbGeAlD
Diclofenac—CYP1A1—head—skin cancer	0.000181	0.00424	CbGeAlD
Diclofenac—CYP2B6—head—skin cancer	0.000175	0.00412	CbGeAlD
Diclofenac—CYP2E1—head—skin cancer	0.000165	0.00387	CbGeAlD
Diclofenac—ABCC1—lymph node—skin cancer	0.000161	0.00378	CbGeAlD
Diclofenac—PTGS1—head—skin cancer	0.000159	0.00373	CbGeAlD
Diclofenac—CYP3A4—female reproductive system—skin cancer	0.000159	0.00373	CbGeAlD
Diclofenac—PTGS2—head—skin cancer	0.000152	0.00356	CbGeAlD
Diclofenac—ABCB1—epithelium—skin cancer	0.000151	0.00355	CbGeAlD
Diclofenac—ABCB1—mammalian vulva—skin cancer	0.000131	0.00308	CbGeAlD
Diclofenac—CYP1A1—lymph node—skin cancer	0.000126	0.00297	CbGeAlD
Diclofenac—Discomfort—Bleomycin—skin cancer	0.000118	0.000639	CcSEcCtD
Diclofenac—Malaise—Dactinomycin—skin cancer	0.000118	0.000639	CcSEcCtD
Diclofenac—Cramp muscle—Docetaxel—skin cancer	0.000118	0.000638	CcSEcCtD
Diclofenac—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000118	0.000638	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000118	0.000638	CcSEcCtD
Diclofenac—Leukopenia—Dactinomycin—skin cancer	0.000117	0.000634	CcSEcCtD
Diclofenac—Nasopharyngitis—Docetaxel—skin cancer	0.000117	0.000633	CcSEcCtD
Diclofenac—ABCB1—lymphoid tissue—skin cancer	0.000116	0.00274	CbGeAlD
Diclofenac—Dysgeusia—Temozolomide—skin cancer	0.000116	0.000628	CcSEcCtD
Diclofenac—Asthenia—Imiquimod—skin cancer	0.000116	0.000626	CcSEcCtD
Diclofenac—Confusional state—Bleomycin—skin cancer	0.000116	0.000625	CcSEcCtD
Diclofenac—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000116	0.000624	CcSEcCtD
Diclofenac—Anaphylactic shock—Bleomycin—skin cancer	0.000115	0.00062	CcSEcCtD
Diclofenac—Oedema—Bleomycin—skin cancer	0.000115	0.00062	CcSEcCtD
Diclofenac—Back pain—Temozolomide—skin cancer	0.000115	0.00062	CcSEcCtD
Diclofenac—Pruritus—Imiquimod—skin cancer	0.000114	0.000618	CcSEcCtD
Diclofenac—Infection—Bleomycin—skin cancer	0.000114	0.000616	CcSEcCtD
Diclofenac—Nausea—Vemurafenib—skin cancer	0.000113	0.000608	CcSEcCtD
Diclofenac—Thrombocytopenia—Bleomycin—skin cancer	0.000112	0.000607	CcSEcCtD
Diclofenac—ABCB1—female reproductive system—skin cancer	0.000112	0.00264	CbGeAlD
Diclofenac—Arrhythmia—Fluorouracil—skin cancer	0.000112	0.000606	CcSEcCtD
Diclofenac—Vision blurred—Temozolomide—skin cancer	0.000112	0.000604	CcSEcCtD
Diclofenac—Myalgia—Dactinomycin—skin cancer	0.000112	0.000603	CcSEcCtD
Diclofenac—Bronchospasm—Docetaxel—skin cancer	0.000111	0.000602	CcSEcCtD
Diclofenac—Tremor—Temozolomide—skin cancer	0.000111	0.000601	CcSEcCtD
Diclofenac—PTGS1—lymph node—skin cancer	0.000111	0.00261	CbGeAlD
Diclofenac—Alopecia—Fluorouracil—skin cancer	0.000111	0.0006	CcSEcCtD
Diclofenac—Diarrhoea—Imiquimod—skin cancer	0.000111	0.000597	CcSEcCtD
Diclofenac—Discomfort—Dactinomycin—skin cancer	0.00011	0.000596	CcSEcCtD
Diclofenac—Angina pectoris—Docetaxel—skin cancer	0.00011	0.000596	CcSEcCtD
Diclofenac—Ill-defined disorder—Temozolomide—skin cancer	0.00011	0.000595	CcSEcCtD
Diclofenac—Anaemia—Temozolomide—skin cancer	0.00011	0.000593	CcSEcCtD
Diclofenac—Anorexia—Bleomycin—skin cancer	0.000109	0.000591	CcSEcCtD
Diclofenac—Erythema—Fluorouracil—skin cancer	0.000109	0.000591	CcSEcCtD
Diclofenac—Agitation—Temozolomide—skin cancer	0.000109	0.000589	CcSEcCtD
Diclofenac—Angioedema—Temozolomide—skin cancer	0.000108	0.000586	CcSEcCtD
Diclofenac—Pancytopenia—Docetaxel—skin cancer	0.000108	0.000581	CcSEcCtD
Diclofenac—Hypotension—Bleomycin—skin cancer	0.000107	0.00058	CcSEcCtD
Diclofenac—Oedema—Dactinomycin—skin cancer	0.000107	0.000579	CcSEcCtD
Diclofenac—Malaise—Temozolomide—skin cancer	0.000107	0.000578	CcSEcCtD
Diclofenac—Dizziness—Imiquimod—skin cancer	0.000107	0.000577	CcSEcCtD
Diclofenac—Vertigo—Temozolomide—skin cancer	0.000107	0.000576	CcSEcCtD
Diclofenac—Infection—Dactinomycin—skin cancer	0.000106	0.000575	CcSEcCtD
Diclofenac—Leukopenia—Temozolomide—skin cancer	0.000106	0.000574	CcSEcCtD
Diclofenac—PTGS2—lymph node—skin cancer	0.000106	0.0025	CbGeAlD
Diclofenac—Palpitations—Temozolomide—skin cancer	0.000105	0.000567	CcSEcCtD
Diclofenac—Thrombocytopenia—Dactinomycin—skin cancer	0.000105	0.000566	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000105	0.000565	CcSEcCtD
Diclofenac—Cough—Temozolomide—skin cancer	0.000104	0.000559	CcSEcCtD
Diclofenac—Paraesthesia—Bleomycin—skin cancer	0.000103	0.000557	CcSEcCtD
Diclofenac—Weight increased—Docetaxel—skin cancer	0.000103	0.000557	CcSEcCtD
Diclofenac—Vision blurred—Fluorouracil—skin cancer	0.000103	0.000557	CcSEcCtD
Diclofenac—Convulsion—Temozolomide—skin cancer	0.000103	0.000555	CcSEcCtD
Diclofenac—Vomiting—Imiquimod—skin cancer	0.000103	0.000555	CcSEcCtD
Diclofenac—Weight decreased—Docetaxel—skin cancer	0.000102	0.000554	CcSEcCtD
Diclofenac—Hypertension—Temozolomide—skin cancer	0.000102	0.000554	CcSEcCtD
Diclofenac—Dyspnoea—Bleomycin—skin cancer	0.000102	0.000553	CcSEcCtD
Diclofenac—Anorexia—Dactinomycin—skin cancer	0.000102	0.000551	CcSEcCtD
Diclofenac—Rash—Imiquimod—skin cancer	0.000102	0.000551	CcSEcCtD
Diclofenac—Dermatitis—Imiquimod—skin cancer	0.000102	0.00055	CcSEcCtD
Diclofenac—Pneumonia—Docetaxel—skin cancer	0.000102	0.000549	CcSEcCtD
Diclofenac—Headache—Imiquimod—skin cancer	0.000101	0.000547	CcSEcCtD
Diclofenac—Anaemia—Fluorouracil—skin cancer	0.000101	0.000546	CcSEcCtD
Diclofenac—Myalgia—Temozolomide—skin cancer	0.000101	0.000546	CcSEcCtD
Diclofenac—Arthralgia—Temozolomide—skin cancer	0.000101	0.000546	CcSEcCtD
Diclofenac—Infestation—Docetaxel—skin cancer	0.000101	0.000546	CcSEcCtD
Diclofenac—Infestation NOS—Docetaxel—skin cancer	0.000101	0.000546	CcSEcCtD
Diclofenac—Anxiety—Temozolomide—skin cancer	0.000101	0.000544	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.0001	0.000542	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.0001	0.000541	CcSEcCtD
Diclofenac—Discomfort—Temozolomide—skin cancer	9.98e-05	0.000539	CcSEcCtD
Diclofenac—Decreased appetite—Bleomycin—skin cancer	9.98e-05	0.000539	CcSEcCtD
Diclofenac—Acute coronary syndrome—Docetaxel—skin cancer	9.95e-05	0.000538	CcSEcCtD
Diclofenac—Renal failure—Docetaxel—skin cancer	9.93e-05	0.000536	CcSEcCtD
Diclofenac—Neuropathy peripheral—Docetaxel—skin cancer	9.9e-05	0.000535	CcSEcCtD
Diclofenac—Myocardial infarction—Docetaxel—skin cancer	9.9e-05	0.000535	CcSEcCtD
Diclofenac—Dry mouth—Temozolomide—skin cancer	9.88e-05	0.000534	CcSEcCtD
Diclofenac—Stomatitis—Docetaxel—skin cancer	9.84e-05	0.000532	CcSEcCtD
Diclofenac—Jaundice—Docetaxel—skin cancer	9.84e-05	0.000532	CcSEcCtD
Diclofenac—Pain—Bleomycin—skin cancer	9.82e-05	0.00053	CcSEcCtD
Diclofenac—Conjunctivitis—Docetaxel—skin cancer	9.81e-05	0.00053	CcSEcCtD
Diclofenac—Leukopenia—Fluorouracil—skin cancer	9.79e-05	0.000529	CcSEcCtD
Diclofenac—Confusional state—Temozolomide—skin cancer	9.76e-05	0.000528	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Dactinomycin—skin cancer	9.75e-05	0.000527	CcSEcCtD
Diclofenac—Anaphylactic shock—Temozolomide—skin cancer	9.68e-05	0.000523	CcSEcCtD
Diclofenac—Oedema—Temozolomide—skin cancer	9.68e-05	0.000523	CcSEcCtD
Diclofenac—Infection—Temozolomide—skin cancer	9.62e-05	0.00052	CcSEcCtD
Diclofenac—Nausea—Imiquimod—skin cancer	9.6e-05	0.000519	CcSEcCtD
Diclofenac—Hepatobiliary disease—Docetaxel—skin cancer	9.55e-05	0.000516	CcSEcCtD
Diclofenac—Epistaxis—Docetaxel—skin cancer	9.52e-05	0.000515	CcSEcCtD
Diclofenac—Nervous system disorder—Temozolomide—skin cancer	9.5e-05	0.000513	CcSEcCtD
Diclofenac—Thrombocytopenia—Temozolomide—skin cancer	9.48e-05	0.000512	CcSEcCtD
Diclofenac—Convulsion—Fluorouracil—skin cancer	9.47e-05	0.000512	CcSEcCtD
Diclofenac—Feeling abnormal—Bleomycin—skin cancer	9.46e-05	0.000511	CcSEcCtD
Diclofenac—Agranulocytosis—Docetaxel—skin cancer	9.42e-05	0.000509	CcSEcCtD
Diclofenac—Skin disorder—Temozolomide—skin cancer	9.41e-05	0.000508	CcSEcCtD
Diclofenac—ABCB1—head—skin cancer	9.38e-05	0.0022	CbGeAlD
Diclofenac—Hyperhidrosis—Temozolomide—skin cancer	9.36e-05	0.000506	CcSEcCtD
Diclofenac—Chest pain—Fluorouracil—skin cancer	9.31e-05	0.000503	CcSEcCtD
Diclofenac—Myalgia—Fluorouracil—skin cancer	9.31e-05	0.000503	CcSEcCtD
Diclofenac—Decreased appetite—Dactinomycin—skin cancer	9.31e-05	0.000503	CcSEcCtD
Diclofenac—Fatigue—Dactinomycin—skin cancer	9.23e-05	0.000499	CcSEcCtD
Diclofenac—Anorexia—Temozolomide—skin cancer	9.23e-05	0.000499	CcSEcCtD
Diclofenac—Discomfort—Fluorouracil—skin cancer	9.2e-05	0.000497	CcSEcCtD
Diclofenac—Pain—Dactinomycin—skin cancer	9.16e-05	0.000495	CcSEcCtD
Diclofenac—Urticaria—Bleomycin—skin cancer	9.12e-05	0.000493	CcSEcCtD
Diclofenac—Haemoglobin—Docetaxel—skin cancer	9.11e-05	0.000492	CcSEcCtD
Diclofenac—Rhinitis—Docetaxel—skin cancer	9.09e-05	0.000491	CcSEcCtD
Diclofenac—Body temperature increased—Bleomycin—skin cancer	9.08e-05	0.00049	CcSEcCtD
Diclofenac—Haemorrhage—Docetaxel—skin cancer	9.06e-05	0.00049	CcSEcCtD
Diclofenac—Hepatitis—Docetaxel—skin cancer	9.06e-05	0.00049	CcSEcCtD
Diclofenac—Hypoaesthesia—Docetaxel—skin cancer	9.02e-05	0.000487	CcSEcCtD
Diclofenac—Confusional state—Fluorouracil—skin cancer	9e-05	0.000486	CcSEcCtD
Diclofenac—Pharyngitis—Docetaxel—skin cancer	9e-05	0.000486	CcSEcCtD
Diclofenac—Urinary tract disorder—Docetaxel—skin cancer	8.95e-05	0.000484	CcSEcCtD
Diclofenac—Oedema peripheral—Docetaxel—skin cancer	8.93e-05	0.000482	CcSEcCtD
Diclofenac—Anaphylactic shock—Fluorouracil—skin cancer	8.92e-05	0.000482	CcSEcCtD
Diclofenac—Oedema—Fluorouracil—skin cancer	8.92e-05	0.000482	CcSEcCtD
Diclofenac—Urethral disorder—Docetaxel—skin cancer	8.89e-05	0.00048	CcSEcCtD
Diclofenac—Infection—Fluorouracil—skin cancer	8.86e-05	0.000479	CcSEcCtD
Diclofenac—Feeling abnormal—Dactinomycin—skin cancer	8.82e-05	0.000477	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Temozolomide—skin cancer	8.82e-05	0.000477	CcSEcCtD
Diclofenac—Insomnia—Temozolomide—skin cancer	8.76e-05	0.000473	CcSEcCtD
Diclofenac—Gastrointestinal pain—Dactinomycin—skin cancer	8.75e-05	0.000473	CcSEcCtD
Diclofenac—Nervous system disorder—Fluorouracil—skin cancer	8.75e-05	0.000473	CcSEcCtD
Diclofenac—Thrombocytopenia—Fluorouracil—skin cancer	8.74e-05	0.000472	CcSEcCtD
Diclofenac—Visual impairment—Docetaxel—skin cancer	8.74e-05	0.000472	CcSEcCtD
Diclofenac—Tachycardia—Fluorouracil—skin cancer	8.71e-05	0.000471	CcSEcCtD
Diclofenac—Paraesthesia—Temozolomide—skin cancer	8.7e-05	0.00047	CcSEcCtD
Diclofenac—Dyspnoea—Temozolomide—skin cancer	8.63e-05	0.000466	CcSEcCtD
Diclofenac—Somnolence—Temozolomide—skin cancer	8.61e-05	0.000465	CcSEcCtD
Diclofenac—Erythema multiforme—Docetaxel—skin cancer	8.57e-05	0.000463	CcSEcCtD
Diclofenac—Dyspepsia—Temozolomide—skin cancer	8.52e-05	0.000461	CcSEcCtD
Diclofenac—Anorexia—Fluorouracil—skin cancer	8.5e-05	0.00046	CcSEcCtD
Diclofenac—Eye disorder—Docetaxel—skin cancer	8.47e-05	0.000458	CcSEcCtD
Diclofenac—Abdominal pain—Dactinomycin—skin cancer	8.46e-05	0.000457	CcSEcCtD
Diclofenac—Body temperature increased—Dactinomycin—skin cancer	8.46e-05	0.000457	CcSEcCtD
Diclofenac—Hypersensitivity—Bleomycin—skin cancer	8.46e-05	0.000457	CcSEcCtD
Diclofenac—Decreased appetite—Temozolomide—skin cancer	8.42e-05	0.000455	CcSEcCtD
Diclofenac—Cardiac disorder—Docetaxel—skin cancer	8.41e-05	0.000455	CcSEcCtD
Diclofenac—Flushing—Docetaxel—skin cancer	8.41e-05	0.000455	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Temozolomide—skin cancer	8.36e-05	0.000452	CcSEcCtD
Diclofenac—Fatigue—Temozolomide—skin cancer	8.35e-05	0.000451	CcSEcCtD
Diclofenac—Hypotension—Fluorouracil—skin cancer	8.34e-05	0.00045	CcSEcCtD
Diclofenac—Pain—Temozolomide—skin cancer	8.28e-05	0.000447	CcSEcCtD
Diclofenac—Constipation—Temozolomide—skin cancer	8.28e-05	0.000447	CcSEcCtD
Diclofenac—Asthenia—Bleomycin—skin cancer	8.24e-05	0.000445	CcSEcCtD
Diclofenac—Angiopathy—Docetaxel—skin cancer	8.22e-05	0.000444	CcSEcCtD
Diclofenac—Immune system disorder—Docetaxel—skin cancer	8.19e-05	0.000442	CcSEcCtD
Diclofenac—Mediastinal disorder—Docetaxel—skin cancer	8.17e-05	0.000441	CcSEcCtD
Diclofenac—Chills—Docetaxel—skin cancer	8.13e-05	0.000439	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Fluorouracil—skin cancer	8.13e-05	0.000439	CcSEcCtD
Diclofenac—Pruritus—Bleomycin—skin cancer	8.12e-05	0.000439	CcSEcCtD
Diclofenac—Arrhythmia—Docetaxel—skin cancer	8.1e-05	0.000438	CcSEcCtD
Diclofenac—Insomnia—Fluorouracil—skin cancer	8.07e-05	0.000436	CcSEcCtD
Diclofenac—Paraesthesia—Fluorouracil—skin cancer	8.01e-05	0.000433	CcSEcCtD
Diclofenac—Alopecia—Docetaxel—skin cancer	8.01e-05	0.000433	CcSEcCtD
Diclofenac—Feeling abnormal—Temozolomide—skin cancer	7.98e-05	0.000431	CcSEcCtD
Diclofenac—Dyspnoea—Fluorouracil—skin cancer	7.95e-05	0.00043	CcSEcCtD
Diclofenac—Mental disorder—Docetaxel—skin cancer	7.94e-05	0.000429	CcSEcCtD
Diclofenac—Somnolence—Fluorouracil—skin cancer	7.93e-05	0.000429	CcSEcCtD
Diclofenac—Gastrointestinal pain—Temozolomide—skin cancer	7.92e-05	0.000428	CcSEcCtD
Diclofenac—Erythema—Docetaxel—skin cancer	7.89e-05	0.000426	CcSEcCtD
Diclofenac—Malnutrition—Docetaxel—skin cancer	7.89e-05	0.000426	CcSEcCtD
Diclofenac—Hypersensitivity—Dactinomycin—skin cancer	7.89e-05	0.000426	CcSEcCtD
Diclofenac—Dyspepsia—Fluorouracil—skin cancer	7.85e-05	0.000424	CcSEcCtD
Diclofenac—Decreased appetite—Fluorouracil—skin cancer	7.76e-05	0.000419	CcSEcCtD
Diclofenac—Dysgeusia—Docetaxel—skin cancer	7.73e-05	0.000418	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Fluorouracil—skin cancer	7.7e-05	0.000416	CcSEcCtD
Diclofenac—Urticaria—Temozolomide—skin cancer	7.69e-05	0.000416	CcSEcCtD
Diclofenac—Asthenia—Dactinomycin—skin cancer	7.68e-05	0.000415	CcSEcCtD
Diclofenac—Body temperature increased—Temozolomide—skin cancer	7.66e-05	0.000414	CcSEcCtD
Diclofenac—Abdominal pain—Temozolomide—skin cancer	7.66e-05	0.000414	CcSEcCtD
Diclofenac—Back pain—Docetaxel—skin cancer	7.63e-05	0.000412	CcSEcCtD
Diclofenac—Pain—Fluorouracil—skin cancer	7.63e-05	0.000412	CcSEcCtD
Diclofenac—Muscle spasms—Docetaxel—skin cancer	7.59e-05	0.00041	CcSEcCtD
Diclofenac—Feeling abnormal—Fluorouracil—skin cancer	7.35e-05	0.000397	CcSEcCtD
Diclofenac—Diarrhoea—Dactinomycin—skin cancer	7.33e-05	0.000396	CcSEcCtD
Diclofenac—Vomiting—Bleomycin—skin cancer	7.3e-05	0.000394	CcSEcCtD
Diclofenac—Anaemia—Docetaxel—skin cancer	7.29e-05	0.000394	CcSEcCtD
Diclofenac—Rash—Bleomycin—skin cancer	7.24e-05	0.000391	CcSEcCtD
Diclofenac—Dermatitis—Bleomycin—skin cancer	7.23e-05	0.000391	CcSEcCtD
Diclofenac—Hypersensitivity—Temozolomide—skin cancer	7.13e-05	0.000386	CcSEcCtD
Diclofenac—Urticaria—Fluorouracil—skin cancer	7.09e-05	0.000383	CcSEcCtD
Diclofenac—Syncope—Docetaxel—skin cancer	7.08e-05	0.000382	CcSEcCtD
Diclofenac—Leukopenia—Docetaxel—skin cancer	7.06e-05	0.000382	CcSEcCtD
Diclofenac—Body temperature increased—Fluorouracil—skin cancer	7.05e-05	0.000381	CcSEcCtD
Diclofenac—Palpitations—Docetaxel—skin cancer	6.97e-05	0.000377	CcSEcCtD
Diclofenac—Asthenia—Temozolomide—skin cancer	6.95e-05	0.000375	CcSEcCtD
Diclofenac—Loss of consciousness—Docetaxel—skin cancer	6.94e-05	0.000375	CcSEcCtD
Diclofenac—Cough—Docetaxel—skin cancer	6.89e-05	0.000372	CcSEcCtD
Diclofenac—Pruritus—Temozolomide—skin cancer	6.85e-05	0.00037	CcSEcCtD
Diclofenac—Convulsion—Docetaxel—skin cancer	6.84e-05	0.000369	CcSEcCtD
Diclofenac—Nausea—Bleomycin—skin cancer	6.82e-05	0.000368	CcSEcCtD
Diclofenac—Hypertension—Docetaxel—skin cancer	6.81e-05	0.000368	CcSEcCtD
Diclofenac—Vomiting—Dactinomycin—skin cancer	6.81e-05	0.000368	CcSEcCtD
Diclofenac—Rash—Dactinomycin—skin cancer	6.75e-05	0.000365	CcSEcCtD
Diclofenac—Arthralgia—Docetaxel—skin cancer	6.72e-05	0.000363	CcSEcCtD
Diclofenac—Chest pain—Docetaxel—skin cancer	6.72e-05	0.000363	CcSEcCtD
Diclofenac—Myalgia—Docetaxel—skin cancer	6.72e-05	0.000363	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	6.67e-05	0.00036	CcSEcCtD
Diclofenac—Diarrhoea—Temozolomide—skin cancer	6.63e-05	0.000358	CcSEcCtD
Diclofenac—Hypersensitivity—Fluorouracil—skin cancer	6.57e-05	0.000355	CcSEcCtD
Diclofenac—Dry mouth—Docetaxel—skin cancer	6.57e-05	0.000355	CcSEcCtD
Diclofenac—ABCB1—lymph node—skin cancer	6.57e-05	0.00154	CbGeAlD
Diclofenac—Confusional state—Docetaxel—skin cancer	6.49e-05	0.000351	CcSEcCtD
Diclofenac—Oedema—Docetaxel—skin cancer	6.44e-05	0.000348	CcSEcCtD
Diclofenac—Anaphylactic shock—Docetaxel—skin cancer	6.44e-05	0.000348	CcSEcCtD
Diclofenac—Dizziness—Temozolomide—skin cancer	6.4e-05	0.000346	CcSEcCtD
Diclofenac—Infection—Docetaxel—skin cancer	6.4e-05	0.000346	CcSEcCtD
Diclofenac—Nausea—Dactinomycin—skin cancer	6.36e-05	0.000344	CcSEcCtD
Diclofenac—Shock—Docetaxel—skin cancer	6.34e-05	0.000342	CcSEcCtD
Diclofenac—Nervous system disorder—Docetaxel—skin cancer	6.32e-05	0.000341	CcSEcCtD
Diclofenac—Pruritus—Fluorouracil—skin cancer	6.31e-05	0.000341	CcSEcCtD
Diclofenac—Thrombocytopenia—Docetaxel—skin cancer	6.31e-05	0.000341	CcSEcCtD
Diclofenac—Tachycardia—Docetaxel—skin cancer	6.29e-05	0.00034	CcSEcCtD
Diclofenac—Skin disorder—Docetaxel—skin cancer	6.26e-05	0.000338	CcSEcCtD
Diclofenac—Vomiting—Temozolomide—skin cancer	6.16e-05	0.000333	CcSEcCtD
Diclofenac—Anorexia—Docetaxel—skin cancer	6.14e-05	0.000332	CcSEcCtD
Diclofenac—Rash—Temozolomide—skin cancer	6.11e-05	0.00033	CcSEcCtD
Diclofenac—Diarrhoea—Fluorouracil—skin cancer	6.1e-05	0.00033	CcSEcCtD
Diclofenac—Dermatitis—Temozolomide—skin cancer	6.1e-05	0.00033	CcSEcCtD
Diclofenac—Headache—Temozolomide—skin cancer	6.07e-05	0.000328	CcSEcCtD
Diclofenac—Hypotension—Docetaxel—skin cancer	6.02e-05	0.000325	CcSEcCtD
Diclofenac—Dizziness—Fluorouracil—skin cancer	5.9e-05	0.000319	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Docetaxel—skin cancer	5.87e-05	0.000317	CcSEcCtD
Diclofenac—Insomnia—Docetaxel—skin cancer	5.82e-05	0.000315	CcSEcCtD
Diclofenac—Paraesthesia—Docetaxel—skin cancer	5.78e-05	0.000312	CcSEcCtD
Diclofenac—Nausea—Temozolomide—skin cancer	5.75e-05	0.000311	CcSEcCtD
Diclofenac—Dyspnoea—Docetaxel—skin cancer	5.74e-05	0.00031	CcSEcCtD
Diclofenac—Somnolence—Docetaxel—skin cancer	5.72e-05	0.000309	CcSEcCtD
Diclofenac—Vomiting—Fluorouracil—skin cancer	5.67e-05	0.000307	CcSEcCtD
Diclofenac—Dyspepsia—Docetaxel—skin cancer	5.67e-05	0.000306	CcSEcCtD
Diclofenac—Rash—Fluorouracil—skin cancer	5.63e-05	0.000304	CcSEcCtD
Diclofenac—Dermatitis—Fluorouracil—skin cancer	5.62e-05	0.000304	CcSEcCtD
Diclofenac—Decreased appetite—Docetaxel—skin cancer	5.6e-05	0.000302	CcSEcCtD
Diclofenac—Headache—Fluorouracil—skin cancer	5.59e-05	0.000302	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Docetaxel—skin cancer	5.56e-05	0.0003	CcSEcCtD
Diclofenac—Fatigue—Docetaxel—skin cancer	5.55e-05	0.0003	CcSEcCtD
Diclofenac—Pain—Docetaxel—skin cancer	5.51e-05	0.000298	CcSEcCtD
Diclofenac—Constipation—Docetaxel—skin cancer	5.51e-05	0.000298	CcSEcCtD
Diclofenac—Feeling abnormal—Docetaxel—skin cancer	5.31e-05	0.000287	CcSEcCtD
Diclofenac—Nausea—Fluorouracil—skin cancer	5.3e-05	0.000286	CcSEcCtD
Diclofenac—Gastrointestinal pain—Docetaxel—skin cancer	5.27e-05	0.000285	CcSEcCtD
Diclofenac—Abdominal pain—Docetaxel—skin cancer	5.09e-05	0.000275	CcSEcCtD
Diclofenac—Body temperature increased—Docetaxel—skin cancer	5.09e-05	0.000275	CcSEcCtD
Diclofenac—Hypersensitivity—Docetaxel—skin cancer	4.74e-05	0.000256	CcSEcCtD
Diclofenac—Asthenia—Docetaxel—skin cancer	4.62e-05	0.00025	CcSEcCtD
Diclofenac—Pruritus—Docetaxel—skin cancer	4.56e-05	0.000246	CcSEcCtD
Diclofenac—Diarrhoea—Docetaxel—skin cancer	4.41e-05	0.000238	CcSEcCtD
Diclofenac—Dizziness—Docetaxel—skin cancer	4.26e-05	0.00023	CcSEcCtD
Diclofenac—Vomiting—Docetaxel—skin cancer	4.09e-05	0.000221	CcSEcCtD
Diclofenac—Rash—Docetaxel—skin cancer	4.06e-05	0.000219	CcSEcCtD
Diclofenac—Dermatitis—Docetaxel—skin cancer	4.06e-05	0.000219	CcSEcCtD
Diclofenac—CXCL8—Cellular responses to stress—CDKN2A—skin cancer	4.04e-05	0.000919	CbGpPWpGaD
Diclofenac—Headache—Docetaxel—skin cancer	4.03e-05	0.000218	CcSEcCtD
Diclofenac—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	3.98e-05	0.000905	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PLIN2—skin cancer	3.98e-05	0.000904	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—FOXO4—skin cancer	3.95e-05	0.000898	CbGpPWpGaD
Diclofenac—KCNQ2—Axon guidance—KRAS—skin cancer	3.93e-05	0.000894	CbGpPWpGaD
Diclofenac—KCNQ3—Axon guidance—KRAS—skin cancer	3.93e-05	0.000894	CbGpPWpGaD
Diclofenac—CXCL8—Spinal Cord Injury—IL6—skin cancer	3.92e-05	0.000892	CbGpPWpGaD
Diclofenac—Nausea—Docetaxel—skin cancer	3.83e-05	0.000207	CcSEcCtD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.82e-05	0.000868	CbGpPWpGaD
Diclofenac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	3.82e-05	0.000867	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.8e-05	0.000863	CbGpPWpGaD
Diclofenac—TTR—Disease—FOXO4—skin cancer	3.8e-05	0.000863	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	3.79e-05	0.000862	CbGpPWpGaD
Diclofenac—KCNQ3—Neuronal System—HRAS—skin cancer	3.77e-05	0.000856	CbGpPWpGaD
Diclofenac—KCNQ2—Neuronal System—HRAS—skin cancer	3.77e-05	0.000856	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—PTGER4—skin cancer	3.76e-05	0.000855	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—SHH—skin cancer	3.7e-05	0.000842	CbGpPWpGaD
Diclofenac—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	3.55e-05	0.000806	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.55e-05	0.000806	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—PTCH1—skin cancer	3.51e-05	0.000798	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—SMO—skin cancer	3.51e-05	0.000798	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—NRAS—skin cancer	3.46e-05	0.000787	CbGpPWpGaD
Diclofenac—CXCL8—Regulation of toll-like receptor signaling pathway—IL6—skin cancer	3.44e-05	0.000782	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.42e-05	0.000778	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—PTGER4—skin cancer	3.42e-05	0.000777	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.41e-05	0.000775	CbGpPWpGaD
Diclofenac—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	3.39e-05	0.00077	CbGpPWpGaD
Diclofenac—KCNQ2—Axon guidance—HRAS—skin cancer	3.34e-05	0.00076	CbGpPWpGaD
Diclofenac—KCNQ3—Axon guidance—HRAS—skin cancer	3.34e-05	0.00076	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—ENO2—skin cancer	3.33e-05	0.000757	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—CSPG4—skin cancer	3.3e-05	0.000749	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SHH—skin cancer	3.26e-05	0.000741	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—NRAS—skin cancer	3.26e-05	0.000741	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—NRAS—skin cancer	3.26e-05	0.000741	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—RASA1—skin cancer	3.24e-05	0.000737	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PLIN2—skin cancer	3.23e-05	0.000734	CbGpPWpGaD
Diclofenac—ALB—Selenium Micronutrient Network—PTGS2—skin cancer	3.23e-05	0.000734	CbGpPWpGaD
Diclofenac—PTGS2—C-MYB transcription factor network—NRAS—skin cancer	3.22e-05	0.000732	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—GLI2—skin cancer	3.22e-05	0.000731	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—CSPG4—skin cancer	3.21e-05	0.000729	CbGpPWpGaD
Diclofenac—KCNQ3—Axon guidance—IL6—skin cancer	3.2e-05	0.000727	CbGpPWpGaD
Diclofenac—KCNQ2—Axon guidance—IL6—skin cancer	3.2e-05	0.000727	CbGpPWpGaD
Diclofenac—CXCL8—SIDS Susceptibility Pathways—IL6—skin cancer	3.14e-05	0.000713	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PLIN2—skin cancer	3.12e-05	0.000708	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	3.11e-05	0.000707	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PTCH1—skin cancer	3.09e-05	0.000703	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SMO—skin cancer	3.09e-05	0.000703	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MC1R—skin cancer	3.07e-05	0.000698	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—GLI1—skin cancer	3.03e-05	0.000688	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PTGER4—skin cancer	3.01e-05	0.000684	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	3e-05	0.000682	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	3e-05	0.000682	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CSPG4—skin cancer	3e-05	0.000682	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—KRAS—skin cancer	2.98e-05	0.000677	CbGpPWpGaD
Diclofenac—CXCL8—Cellular Senescence—TP53—skin cancer	2.98e-05	0.000677	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.95e-05	0.000671	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SUFU—skin cancer	2.87e-05	0.000652	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—KRAS—skin cancer	2.81e-05	0.000638	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—KRAS—skin cancer	2.81e-05	0.000638	CbGpPWpGaD
Diclofenac—PTGS2—C-MYB transcription factor network—KRAS—skin cancer	2.77e-05	0.00063	CbGpPWpGaD
Diclofenac—PTGS1—Selenium Micronutrient Network—IL6—skin cancer	2.74e-05	0.000622	CbGpPWpGaD
Diclofenac—CXCL8—Cellular Senescence—IL6—skin cancer	2.73e-05	0.00062	CbGpPWpGaD
Diclofenac—ALB—Vitamin B12 Metabolism—IL6—skin cancer	2.72e-05	0.000618	CbGpPWpGaD
Diclofenac—TTR—Disease—ERCC2—skin cancer	2.7e-05	0.000615	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—FOXO4—skin cancer	2.66e-05	0.000604	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.66e-05	0.000604	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TERT—skin cancer	2.64e-05	0.0006	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PLIN2—skin cancer	2.63e-05	0.000599	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—ERCC2—skin cancer	2.63e-05	0.000599	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CSPG4—skin cancer	2.6e-05	0.000592	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.6e-05	0.000592	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.54e-05	0.000577	CbGpPWpGaD
Diclofenac—TTR—Disease—TERT—skin cancer	2.54e-05	0.000576	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—HRAS—skin cancer	2.53e-05	0.000576	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CSPG4—skin cancer	2.51e-05	0.000571	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—NRAS—skin cancer	2.47e-05	0.000561	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—IL6—skin cancer	2.42e-05	0.000551	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—TP53—skin cancer	2.42e-05	0.00055	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—HRAS—skin cancer	2.38e-05	0.000542	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—HRAS—skin cancer	2.38e-05	0.000542	CbGpPWpGaD
Diclofenac—PTGS2—C-MYB transcription factor network—HRAS—skin cancer	2.36e-05	0.000536	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—IL6—skin cancer	2.28e-05	0.000519	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—IL6—skin cancer	2.28e-05	0.000519	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—TP53—skin cancer	2.25e-05	0.000512	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—ENO2—skin cancer	2.24e-05	0.000509	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—NRAS—skin cancer	2.22e-05	0.000505	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—IL6—skin cancer	2.21e-05	0.000503	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SHH—skin cancer	2.19e-05	0.000497	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ENO2—skin cancer	2.18e-05	0.000495	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—RASA1—skin cancer	2.17e-05	0.000494	CbGpPWpGaD
Diclofenac—PTGS2—Selenium Micronutrient Network—IL6—skin cancer	2.17e-05	0.000494	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	2.16e-05	0.000491	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.13e-05	0.000484	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—KRAS—skin cancer	2.13e-05	0.000483	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CSPG4—skin cancer	2.12e-05	0.000483	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PLIN2—skin cancer	2.09e-05	0.000475	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—BRAF—skin cancer	2.09e-05	0.000475	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SMO—skin cancer	2.07e-05	0.000471	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTCH1—skin cancer	2.07e-05	0.000471	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—IL6—skin cancer	2.06e-05	0.000468	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SHH—skin cancer	2.04e-05	0.000463	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ENO2—skin cancer	2.04e-05	0.000463	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTGER4—skin cancer	2.02e-05	0.000459	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CSPG4—skin cancer	2.01e-05	0.000457	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PLIN2—skin cancer	2.01e-05	0.000457	CbGpPWpGaD
Diclofenac—TTR—Disease—BRAF—skin cancer	2.01e-05	0.000456	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PLIN2—skin cancer	1.97e-05	0.000447	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—ERCC2—skin cancer	1.93e-05	0.000439	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—KRAS—skin cancer	1.91e-05	0.000435	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TP53—skin cancer	1.88e-05	0.000427	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PLIN2—skin cancer	1.86e-05	0.000422	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—HRAS—skin cancer	1.81e-05	0.000411	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—FOXO4—skin cancer	1.78e-05	0.000405	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TERT—skin cancer	1.78e-05	0.000404	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ENO2—skin cancer	1.77e-05	0.000402	CbGpPWpGaD
Diclofenac—ALB—Selenium Micronutrient Network—IL6—skin cancer	1.76e-05	0.0004	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—IL6—skin cancer	1.73e-05	0.000393	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—IL6—skin cancer	1.72e-05	0.000391	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ENO2—skin cancer	1.71e-05	0.000388	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PLIN2—skin cancer	1.7e-05	0.000387	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PLIN2—skin cancer	1.69e-05	0.000385	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CSPG4—skin cancer	1.69e-05	0.000383	CbGpPWpGaD
Diclofenac—ABCC1—Disease—FOXO4—skin cancer	1.66e-05	0.000378	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—HRAS—skin cancer	1.63e-05	0.00037	CbGpPWpGaD
Diclofenac—TTR—Disease—PTGS2—skin cancer	1.62e-05	0.000369	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CSPG4—skin cancer	1.62e-05	0.000368	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CSPG4—skin cancer	1.59e-05	0.000361	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—PTGS2—skin cancer	1.58e-05	0.000359	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—IL6—skin cancer	1.56e-05	0.000354	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.52e-05	0.000346	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PLIN2—skin cancer	1.52e-05	0.000345	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CSPG4—skin cancer	1.5e-05	0.00034	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PLIN2—skin cancer	1.48e-05	0.000337	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ENO2—skin cancer	1.44e-05	0.000328	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.44e-05	0.000327	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—BRAF—skin cancer	1.41e-05	0.00032	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PLIN2—skin cancer	1.38e-05	0.000315	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CSPG4—skin cancer	1.37e-05	0.000312	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—NRAS—skin cancer	1.37e-05	0.000311	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SHH—skin cancer	1.37e-05	0.000311	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ENO2—skin cancer	1.37e-05	0.000311	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CSPG4—skin cancer	1.36e-05	0.00031	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.34e-05	0.000303	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—NRAS—skin cancer	1.31e-05	0.000298	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—ERCC2—skin cancer	1.3e-05	0.000296	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.28e-05	0.00029	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—ERCC2—skin cancer	1.27e-05	0.000288	CbGpPWpGaD
Diclofenac—TTR—Disease—NRAS—skin cancer	1.26e-05	0.000287	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CSPG4—skin cancer	1.22e-05	0.000278	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CSPG4—skin cancer	1.19e-05	0.000272	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TERT—skin cancer	1.19e-05	0.000271	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ERCC2—skin cancer	1.18e-05	0.000269	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PLIN2—skin cancer	1.18e-05	0.000269	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—KRAS—skin cancer	1.18e-05	0.000268	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PTGS2—skin cancer	1.16e-05	0.000264	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ENO2—skin cancer	1.15e-05	0.00026	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—KRAS—skin cancer	1.13e-05	0.000257	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.13e-05	0.000257	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CSPG4—skin cancer	1.12e-05	0.000254	CbGpPWpGaD
Diclofenac—PTGS2—Disease—FOXO4—skin cancer	1.12e-05	0.000254	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TERT—skin cancer	1.11e-05	0.000252	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ENO2—skin cancer	1.1e-05	0.00025	CbGpPWpGaD
Diclofenac—TTR—Disease—KRAS—skin cancer	1.09e-05	0.000247	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ENO2—skin cancer	1.08e-05	0.000245	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—skin cancer	1.05e-05	0.000238	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—ERCC2—skin cancer	1.03e-05	0.000234	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.02e-05	0.000232	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ENO2—skin cancer	1.02e-05	0.000231	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—skin cancer	1e-05	0.000228	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—NRAS—skin cancer	1e-05	0.000228	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—HRAS—skin cancer	1e-05	0.000228	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—ERCC2—skin cancer	9.92e-06	0.000225	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HRAS—skin cancer	9.61e-06	0.000218	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CSPG4—skin cancer	9.54e-06	0.000217	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—BRAF—skin cancer	9.43e-06	0.000214	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ENO2—skin cancer	9.32e-06	0.000212	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ENO2—skin cancer	9.27e-06	0.000211	CbGpPWpGaD
Diclofenac—TTR—Disease—HRAS—skin cancer	9.23e-06	0.00021	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—IL6—skin cancer	9.2e-06	0.000209	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PLIN2—skin cancer	9.13e-06	0.000208	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	9.05e-06	0.000206	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NRAS—skin cancer	8.84e-06	0.000201	CbGpPWpGaD
Diclofenac—TTR—Disease—IL6—skin cancer	8.84e-06	0.000201	CbGpPWpGaD
Diclofenac—ABCC1—Disease—BRAF—skin cancer	8.79e-06	0.0002	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—KRAS—skin cancer	8.64e-06	0.000196	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ERCC2—skin cancer	8.38e-06	0.000191	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ENO2—skin cancer	8.32e-06	0.000189	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ENO2—skin cancer	8.12e-06	0.000185	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.95e-06	0.000181	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERCC2—skin cancer	7.95e-06	0.000181	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTGS2—skin cancer	7.8e-06	0.000177	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—KRAS—skin cancer	7.61e-06	0.000173	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTGS2—skin cancer	7.59e-06	0.000172	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ENO2—skin cancer	7.59e-06	0.000172	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TERT—skin cancer	7.45e-06	0.000169	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CSPG4—skin cancer	7.36e-06	0.000167	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HRAS—skin cancer	7.34e-06	0.000167	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.29e-06	0.000166	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	7.25e-06	0.000165	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTGS2—skin cancer	7.1e-06	0.000161	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—IL6—skin cancer	7.03e-06	0.00016	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—skin cancer	6.76e-06	0.000154	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ERCC2—skin cancer	6.66e-06	0.000151	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	6.51e-06	0.000148	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ENO2—skin cancer	6.48e-06	0.000147	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—skin cancer	6.46e-06	0.000147	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ERCC2—skin cancer	6.4e-06	0.000145	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ERCC2—skin cancer	6.27e-06	0.000142	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NRAS—skin cancer	6.2e-06	0.000141	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—skin cancer	6.19e-06	0.000141	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—skin cancer	6.17e-06	0.00014	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—skin cancer	5.95e-06	0.000135	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.93e-06	0.000135	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NRAS—skin cancer	5.93e-06	0.000135	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ERCC2—skin cancer	5.91e-06	0.000134	CbGpPWpGaD
Diclofenac—PTGS2—Disease—BRAF—skin cancer	5.9e-06	0.000134	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NRAS—skin cancer	5.52e-06	0.000126	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ERCC2—skin cancer	5.42e-06	0.000123	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ERCC2—skin cancer	5.38e-06	0.000122	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—skin cancer	5.33e-06	0.000121	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—skin cancer	5.1e-06	0.000116	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.07e-06	0.000115	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—skin cancer	5.03e-06	0.000114	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ENO2—skin cancer	5e-06	0.000114	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ERCC2—skin cancer	4.83e-06	0.00011	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—skin cancer	4.75e-06	0.000108	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—skin cancer	4.74e-06	0.000108	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ERCC2—skin cancer	4.72e-06	0.000107	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—skin cancer	4.53e-06	0.000103	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—skin cancer	4.53e-06	0.000103	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ERCC2—skin cancer	4.41e-06	0.0001	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—skin cancer	4.34e-06	9.86e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—skin cancer	4.15e-06	9.43e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—skin cancer	4.04e-06	9.19e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—skin cancer	3.87e-06	8.79e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—skin cancer	3.84e-06	8.72e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ERCC2—skin cancer	3.77e-06	8.56e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—skin cancer	3.76e-06	8.54e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—skin cancer	3.71e-06	8.43e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—skin cancer	3.54e-06	8.05e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—skin cancer	3.25e-06	7.38e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—skin cancer	3.23e-06	7.34e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—skin cancer	3.19e-06	7.25e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ERCC2—skin cancer	2.91e-06	6.61e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—skin cancer	2.9e-06	6.59e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—skin cancer	2.83e-06	6.43e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—skin cancer	2.71e-06	6.17e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—skin cancer	2.64e-06	6.01e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—skin cancer	2.6e-06	5.9e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—skin cancer	2.26e-06	5.13e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—skin cancer	1.74e-06	3.96e-05	CbGpPWpGaD
